Friday, January 27, 2023 10:44:42 AM
Sharp can announce the reverse merger candidate and fight the share cancellations along the way. Some they will win, some they could lose. But if they are already prepared for the worst case scenario (12.25% of OS don’t get cancelled), it’s not a dealbreaker.
Maybe they only get 1/2 of the 294 million cancelled, maybe 75%, maybe all? Whatever…It’s not like the Calasse share cancellations because Calasse wanted 54% of the company. That would make him the MAJORITY STAKEHOLDER, “Chairman of the Board”, LOL, more than 50.1%. You can’t get a company to move into the shell and announce a reverse merger candidate with that looming over your head. Calasse wants 54% of the outstanding shares.
But here, it’s 12.25%, spread out over 8 people. There is no big risk here like in the Calasse case, of him trying to keep 54% of the company, MAJORITY INTEREST. This is for a MINORITY INTEREST, no control issues with $GVSI share cancellations.
They can announce the reverse merger candidate anytime after Pink Current, move along, and take these share cancellations issues one-by-one, step-by-step, over any length of time. It’s a totally different situation with $GVSI. TOTALLY DIFFERENT.
Sharp even said after these 294.0 million, he’s going to try even get more shares cancelled. Does anyone really think that they are NOT going to move forward until every share cancellation is completed? LMAO. I certainly don’t, these share cancellations are gravy and don’t amount to much in the grand scheme of things.
Sure it would be nice to have all 294.0 million shares cancelled, but everyone is already prepared that they might not get all of them.
Recent GVSI News
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM